DISCLAIMER
These codes are currently under development by the LOINC team, and are subject to change prior to inclusion in a public release. It is possible that they may not be published in the next, or any, public release. They are provided here for informational purposes only.
TIP Click on headings to sort table by that column. Hold down Shift and click additional headings to add to sorting.
TIP In your web browser, use ControlF (or ⌘F on Mac) to find text on this page.
scroll/swipe to view more columns
| Created On | LOINC | Long Common Name | Special Usage | Component | Prop | Time | System | Scale | Method | Shortname |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-08-28 | 93356-4 | Cells with cytogenetic abnormality [#] in Blood or Tissue by Molecular genetics method | Cells.cytogenetic abnormality | Num | Pt | Bld/Tiss | Qn | Molgen | Cells w cytogenetic abnl Bld/T | |
| 2019-08-28 | 93357-2 | Monotypic plasma cell identification and risk stratification panel - Bone marrow by Molecular genetics method | Monotypic plasma cell identification & risk stratification panel | - | Pt | Bone mar | - | Molgen | Mono PC ID + risk Pnl Mar | |
| 2019-08-28 | 93358-0 | Polyclonal plasma cells/Cells counted in Bone marrow by Flow cytometry (FC) | Plasma cells.polyclonal/Cells counted | NFr | Pt | Bone mar | Qn | Flow cytometry | Polyclonal PCs/Cells NFr Mar FC | |
| 2019-08-28 | 93359-8 | Monotypic plasma cell DNA ploidy [Type] in Bone marrow by Flow cytometry (FC) | Monotypic plasma cell DNA ploidy | Type | Pt | Bone mar | Nom | Flow cytometry | Monotypic PC DNA ploidy Mar FC | |
| 2019-08-28 | 93360-6 | Monotypic plasma cell DNA index in Bone marrow by Flow cytometry (FC) | Monotypic plasma cell DNA index | Ratio | Pt | Bone mar | Qn | Flow cytometry | Monotypic PC DNA index Mar FC-Rto | |
| 2019-08-28 | 93362-2 | Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC) | Plasma cells.monotypic population | Prid | Pt | Bone mar | Nom | Flow cytometry | Monotypic plasma cells Mar FC | |
| 2019-08-28 | 93361-4 | Monotypic plasma cells in S phase/100 cells in Bone marrow by Flow cytometry (FC) | Plasma cells.monotypic.S phase/100 cells | NFr | Pt | Bone mar | Qn | Flow cytometry | Mono PC in S Phs NFr Mar FC | |
| 2019-08-28 | 93363-0 | Plasma cell DNA content and proliferation panel - Bone marrow by Flow cytometry (FC) | Plasma cell DNA content & proliferation panel | - | Pt | Bone mar | - | Flow cytometry | PC DNA content + prolif Pnl Mar FC | |
| 2019-08-28 | 93364-8 | Genetic variant diagnostic significance [Interpretation] in Blood or Tissue Narrative | Genetic variant diagnostic significance | Imp | Pt | Bld/Tiss | Nar | Genetic variant diag sig Bld/T-Imp | ||
| 2019-08-28 | 93365-5 | Genetic variant prognostic significance [Interpretation] in Blood or Tissue Narrative | Genetic variant prognostic significance | Imp | Pt | Bld/Tiss | Nar | Genetic variant prog sig Bld/T-Imp | ||
| 2019-08-28 | 93368-9 | Summary of interaction between genetic variants [Interpretation] in Blood or Tissue Narrative | Summary of interaction between genetic variants | Imp | Pt | Bld/Tiss | Nar | Variant interaction summary Bld/T-Imp | ||
| 2019-08-28 | 93366-3 | Gene studied with no variant found [Identifier] in Blood or Tissue Nominal | Gene studied with no variant found | Prid | Pt | Bld/Tiss | Nom | Gene studied w no variant found Bld/T | ||
| 2019-08-28 | 93367-1 | Variant of unknown significance [Identifier] in Blood or Tissue Nominal | Variant of unknown significance | Prid | Pt | Bld/Tiss | Nom | Variant unknown sig Bld/T | ||
| 2019-08-27 | 93313-5 | Platelet glycoprotein disorder [Interpretation] in Blood by Flow cytometry (FC) Narrative | Platelet glycoprotein disorder | Imp | Pt | Bld | Nar | Flow cytometry | Platelet GP disorder Bld FC-Imp | |
| 2019-08-27 | 93314-3 | Platelet glycoprotein VI actual/normal in Blood by Flow cytometry (FC) | Platelet glycoprotein VI actual/normal | RelRto | Pt | Bld | Qn | Flow cytometry | Plt GPVI Act/Nor Bld FC | |
| 2019-08-27 | 93315-0 | Platelet CD49b actual/normal in Blood by Flow cytometry (FC) | Platelet CD49b actual/normal | RelRto | Pt | Bld | Qn | Flow cytometry | Plt CD49b Act/Nor Bld FC | |
| 2019-08-27 | 93316-8 | Platelet CD42b actual/normal in Blood by Flow cytometry (FC) | Platelet CD42b actual/normal | RelRto | Pt | Bld | Qn | Flow cytometry | Plt CD42b Act/Nor Bld FC | |
| 2019-08-27 | 93317-6 | Platelet CD42a actual/normal in Blood by Flow cytometry (FC) | Platelet CD42a actual/normal | RelRto | Pt | Bld | Qn | Flow cytometry | Plt CD42a Act/Nor Bld FC | |
| 2019-08-27 | 93318-4 | Platelet CD61 actual/normal in Blood by Flow cytometry (FC) | Platelet CD61 actual/normal | RelRto | Pt | Bld | Qn | Flow cytometry | Plt CD61 Act/Nor Bld FC | |
| 2019-08-27 | 93319-2 | Platelet CD41 actual/normal in Blood by Flow cytometry (FC) | Platelet CD41 actual/normal | RelRto | Pt | Bld | Qn | Flow cytometry | Plt CD41 Act/Nor Bld FC | |
| 2019-08-27 | 93320-0 | Platelet surface glycoprotein disorders panel - Blood by Flow cytometry (FC) | Platelet glycoprotein disorder panel | - | Pt | Bld | Qn | Flow cytometry | Platelet glycoprotein Pnl Bld FC | |
| 2019-08-27 | 93321-8 | PT mixing study panel - Platelet poor plasma by Coagulation assay | PT mixing study panel | - | Pt | PPP | Qn | Coag | PT mix Pnl PPP | |
| 2019-08-27 | 93322-6 | Ursodeoxycholate [Moles/volume] in Serum or Plasma | Ursodeoxycholate | SCnc | Pt | Ser/Plas | Qn | Ursodeoxycholate SerPl-sCnc | ||
| 2019-08-27 | 93323-4 | Tauroursodeoxycholate [Moles/volume] in Serum or Plasma | Tauroursodeoxycholate | SCnc | Pt | Ser/Plas | Qn | TUDCA SerPl-sCnc | ||
| 2019-08-27 | 93324-2 | Taurolithocholate [Moles/volume] in Serum or Plasma | Taurolithocholate | SCnc | Pt | Ser/Plas | Qn | TLCA SerPl-sCnc | ||
| 2019-08-27 | 93325-9 | Taurohyodeoxycholate [Moles/volume] in Serum or Plasma | Taurohyodeoxycholate | SCnc | Pt | Ser/Plas | Qn | THDCA SerPl-sCnc | ||
| 2019-08-27 | 93326-7 | Taurodeoxycholate [Moles/volume] in Serum or Plasma | Taurodeoxycholate | SCnc | Pt | Ser/Plas | Qn | TDCA SerPl-sCnc | ||
| 2019-08-27 | 93327-5 | Taurocholate [Moles/volume] in Serum or Plasma | Taurocholate | SCnc | Pt | Ser/Plas | Qn | TCA SerPl-sCnc | ||
| 2019-08-27 | 93328-3 | Taurochenodeoxycholate [Moles/volume] in Serum or Plasma | Taurochenodeoxycholate | SCnc | Pt | Ser/Plas | Qn | TCDCA SerPl-sCnc | ||
| 2019-08-27 | 93329-1 | Hyodeoxycholate [Moles/volume] in Serum or Plasma | Hyodeoxycholate | SCnc | Pt | Ser/Plas | Qn | HDCA SerPl-sCnc | ||
| 2019-08-27 | 93330-9 | Glycoursodeoxycholate [Moles/volume] in Serum or Plasma | Glycoursodeoxycholate | SCnc | Pt | Ser/Plas | Qn | GUDCA SerPl-sCnc | ||
| 2019-08-27 | 93331-7 | Glycolithocholate [Moles/volume] in Serum or Plasma | Glycolithocholate | SCnc | Pt | Ser/Plas | Qn | GLCA SerPl-sCnc | ||
| 2019-08-27 | 93332-5 | Glycohyodeoxycholate [Moles/volume] in Serum or Plasma | Glycohyodeoxycholate | SCnc | Pt | Ser/Plas | Qn | Glycohyodeoxycholate SerPl-sCnc | ||
| 2019-08-27 | 93333-3 | Glycodeoxycholate [Moles/volume] in Serum or Plasma | Glycodeoxycholate | SCnc | Pt | Ser/Plas | Qn | GDCA SerPl-sCnc | ||
| 2019-08-27 | 93334-1 | Glycocholate [Moles/volume] in Serum or Plasma | Glycocholate | SCnc | Pt | Ser/Plas | Qn | GCA SerPl-sCnc | ||
| 2019-08-27 | 93335-8 | Glycochenodeoxycholate [Moles/volume] in Serum or Plasma | Glycochenodeoxycholate | SCnc | Pt | Ser/Plas | Qn | GCDCA SerPl-sCnc | ||
| 2019-08-27 | 93336-6 | Bile acid [Moles/time] in 48 hour Stool | Bile acid | SRat | 48H | Stool | Qn | Bile Ac 48h Stl-sRate | ||
| 2019-08-27 | 93337-4 | Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool | Chenodeoxycholate+Cholate/Bile acid.total | SFr | 48H | Stool | Qn | CDCA+CA 48h SFr Stl | ||
| 2019-08-27 | 93338-2 | Bile acid panel - 48 hour Stool | Bile acid panel | - | 48H | Stool | - | Bile acid pnl Stl | ||
| 2019-08-27 | 93339-0 | THSD7A IgG Ab [Presence] in Serum by Immunofluorescence | Thrombospondin type I domain-containing 7A Ab.IgG | PrThr | Pt | Ser/Plas | Ord | IF | THSD7A IgG Ser Ql IF | |
| 2019-08-27 | 93340-8 | PhenX - complete blood count protocol 220501 | PhenX - complete blood count protocol 220501 | - | Pt | ^Patient | - | PhenX | PhenX - CBC protocol | |
| 2019-08-27 | 93341-6 | Medication recommendation | Medication recommendation | Imp | Pt | ^Patient | Nar | Medication recommendation | ||
| 2019-08-27 | 93342-4 | Power level --peak during exercise | Power level^peak during exercise | EngRat | Pt | ^Patient | Qn | Power lev peak W exer | ||
| 2019-08-27 | 93343-2 | Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal | Treatment to which interaction between genetic variants confers synergy | Prid | Pt | Bld/Tiss | Nom | Variant interaction assoc therapy syner | ||
| 2019-08-27 | 93344-0 | Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal | Treatment to which genetic variant confers resistance | Prid | Pt | Bld/Tiss | Nom | Variant assoc therapy resist | ||
| 2019-08-27 | 93345-7 | Genetic variant effect on drug resistance in Blood or Tissue Narrative | Genetic variant effect on drug resistance | Find | Pt | Bld/Tiss | Nar | Variant drug resist effect Nar | ||
| 2019-08-27 | 93346-5 | Genetic variant effect on drug sensitivity in Blood or Tissue Narrative | Genetic variant effect on drug sensitivity | Find | Pt | Bld/Tiss | Nar | Variant drug sens effect Nar | ||
| 2019-08-27 | 93347-3 | Available treatment related to genetic variant and not to patient diagnosis [Identifier] in Blood or Tissue Nominal | Available treatment related to genetic variant and not to patient diagnosis | Prid | Pt | Bld/Tiss | Nom | Avail tx for variant but not dx Bld/T | ||
| 2019-08-27 | 93348-1 | Available treatment related to genetic variant and to patient diagnosis [Identifier] in Blood or Tissue Nominal | Available treatment related to genetic variant and to patient diagnosis | Prid | Pt | Bld/Tiss | Nom | Avail tx for variant+dx Bld/T | ||
| 2019-08-27 | 93349-9 | Treatment to which interaction between genetic variants confers resistance [Identifier] in Blood or Tissue Nominal | Treatment to which interaction between genetic variants confers resistance | Prid | Pt | Bld/Tiss | Nom | Variant interaction assoc therapy resist | ||
| 2019-08-27 | 93350-7 | Monocytes.HLA-DR+/100 Monocytes in Blood by Flow cytometry (FC) | Monocytes.HLA-DR+/100 Monocytes | NFr | Pt | Bld | Qn | Flow cytometry | Mono.HLA-DR+/100 Mono NFr Bld FC | |
| 2019-08-27 | 93351-5 | HLA-DR [Entitic number] on Monocyte by Flow cytometry (FC) | HLA-DR | EntNum | Pt | Monocyte | Qn | Flow cytometry | HLA-DR EntNum Mono FC | |
| 2019-08-27 | 93352-3 | Neutrophils.CD64+/100 Neutrophils in Blood by Flow cytometry (FC) | Neutrophils.CD64+/100 Neutrophils | NFr | Pt | Bld | Qn | Flow cytometry | Neut.CD64+/100 Neut NFr Bld FC | |
| 2019-08-27 | 93353-1 | CD64 [Entitic number] on Neutrophil by Flow cytometry (FC) | CD64 | EntNum | Pt | Neutrophil | Qn | Flow cytometry | CD64 EntNum Neut FC | |
| 2019-08-27 | 93354-9 | Neutrophil CD64 and Monocyte HLA DR panel - Blood by Flow cytometry (FC) | Neutrophil CD64 & Monocyte HLA DR panel | - | Pt | Bld | Qn | Flow cytometry | Neut CD64 + Mono HLA DR Pnl Bld FC | |
| 2019-08-26 | 93306-9 | Genetic risk score for coronary heart disease | Genetic risk score for coronary heart disease | Score | Lifetime | ^Patient | Qn | GRS for CHD | ||
| 2019-08-26 | 93307-7 | Lifetime risk for developing coronary heart disease based on genetic risk score | Lifetime risk for developing coronary heart disease based on genetic risk score | Likelihood | Lifetime | ^Patient | Ord | Lifetime Risk for CHD based on GRS | ||
| 2019-08-26 | 93308-5 | Genetic variation's effect on risk of adverse drug reaction | Risk of adverse drug reaction sequence variation interpretation | Imp | Pt | Bld/Tiss | Nar | Adverse drug seq var interp Bld/T-Imp | ||
| 2019-08-23 | 93232-7 | Imipenem+Relebactam [Susceptibility] by Gradient strip | Imipenem+Relebactam | Susc | Pt | Isolate | OrdQn | Gradient strip | Imi+Rel Islt Grad strip | |
| 2019-08-23 | 93233-5 | Intercellular substance IgG Ab [Presence] in Serum by Immunofluorescence | Intercellular substance Ab.IgG | PrThr | Pt | Ser | Ord | IF | ICS IgG Ser Ql IF | |
| 2019-08-23 | 93234-3 | dRVVT in Platelet poor plasma by Coagulation assay --post heparin neutralization | Coagulation dilute Russell viper venom induced^post heparin neutralization | Time | Pt | PPP | Qn | Coag | dRVVT p hep neut PPP | |
| 2019-08-23 | 93235-0 | aPTT.lupus sensitive in Platelet poor plasma by Coagulation assay --post heparin neutralization | Coagulation surface induced.lupus sensitive^post heparin neutralization | Time | Pt | PPP | Qn | Coag | aPTT-LA p hep neut PPP | |
| 2019-08-23 | 93236-8 | aPTT.lupus sensitive.excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization | Coagulation surface induced.lupus sensitive.excess phospholipid^post heparin neutralization | Time | Pt | PPP | Qn | Coag | aPTT-LA confirm p hep neut PPP | |
| 2019-08-23 | 93237-6 | aPTT.lupus sensitive.excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization | Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal^post heparin neutralization | RelTime | Pt | PPP | Qn | Coag | aPTT-LA confirm Act/Nor p hep neut PPP | |
| 2019-08-23 | 93238-4 | dRVVT excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization | Coagulation dilute Russell viper venom induced.excess phospholipid^post heparin neutralization | Time | Pt | PPP | Qn | Coag | dRVVT confirm p hep neut PPP | |
| 2019-08-23 | 93239-2 | dRVVT excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization | Coagulation dilute Russell viper venom induced.excess phospholipid actual/normal^post heparin neutralization | RelTime | Pt | PPP | Qn | Coag | dRVVT confirm Act/Nor p hep neut PPP | |
| 2019-08-23 | 93240-0 | dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma and heparin neutralization | Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:1 addition of normal plasma+heparin neutralization | Time | Pt | PPP | Qn | Coag | dRVVT imm 1:1 NP+hep neut PPP | |
| 2019-08-23 | 93241-8 | US.doppler Unspecified body region | Multisection | Find | Pt | XXX | Doc | US.doppler | DOP Unsp region | |
| 2019-08-23 | 93242-6 | 11-Ketotestosterone [Mass/volume] in Serum or Plasma | 11-Ketotestosterone | MCnc | Pt | Ser/Plas | Qn | 11Ketotestost SerPl-mCnc | ||
| 2019-08-23 | 93243-4 | 11-Hydroxytestosterone [Mass/volume] in Serum or Plasma | 11-Hydroxytestosterone | MCnc | Pt | Ser/Plas | Qn | 11OH-Testost SerPl-mCnc | ||
| 2019-08-23 | 93244-2 | Complement Sc5b-9 [Mass/volume] in Serum or Plasma by Immunoassay | Complement Sc5b-9 | MCnc | Pt | Ser/Plas | Qn | IA | SC5b9 SerPl IA-mCnc | |
| 2019-08-21 | 93224-4 | Coccidioides sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay | Coccidioides sp Ag | MCnc | Pt | BAL | Qn | IA | Coccidioides Ag BAL IA-mCnc | |
| 2019-08-21 | 93225-1 | Coccidioides sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay | Coccidioides sp Ag | MCnc | Pt | CSF | Qn | IA | Coccidioides Ag CSF IA-mCnc | |
| 2019-08-21 | 93226-9 | Coccidioides sp Ag [Mass/volume] in Serum or Plasma by Immunoassay | Coccidioides sp Ag | MCnc | Pt | Ser/Plas | Qn | IA | Coccidioides Ag SerPl IA-mCnc | |
| 2019-08-21 | 93227-7 | Coccidioides sp Ag [Mass/volume] in Urine by Immunoassay | Coccidioides sp Ag | MCnc | Pt | Urine | Qn | IA | Coccidioides Ag Ur IA-mCnc | |
| 2019-08-20 | 93189-9 | XR Wrist and Hand Total skeletal maturity score | Total skeletal maturity score | Score | Pt | Upper extremity>Wrist+Hand | Qn | XR | XR Wrist+Hand Total maturity score | |
| 2019-08-20 | 93190-7 | HTR2A gene c.614-2211T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal | HTR2A gene.c.614-2211T>C | Geno | Pt | Bld/Tiss | Nom | Molgen | HTR2A c.614-2211T>C Geno Bld/T | |
| 2019-08-20 | 93191-5 | HTR2C gene c.-759C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal | HTR2C gene.c.-759C>T | Geno | Pt | Bld/Tiss | Nom | Molgen | HTR2C c.-759C>T Geno Bld/T | |
| 2019-08-20 | 93192-3 | HTR2C gene c.551-3008C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal | HTR2C gene.c.551-3008C>G | Geno | Pt | Bld/Tiss | Nom | Molgen | HTR2C c.551-3008C>G Geno Bld/T | |
| 2019-08-20 | 93193-1 | TPMT gene and NUDT15 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | TPMT gene & NUDT15 gene targeted mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | TPMT + NUDT15 Mut Anl Bld/T | |
| 2019-08-20 | 93194-9 | NUDT15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NUDT15 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | Molgen | NUDT15 gene Mut Anl Bld/T | |
| 2019-08-20 | 93195-6 | NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative | NUDT15 gene product metabolic activity interpretation | Imp | Pt | Bld/Tiss | Ord | NUDT15 gene prod met act imp Bld/T-Imp | ||
| 2019-08-20 | 93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method | Warfarin response genotype panel | - | Pt | Bld/Tiss | - | Molgen | Warfarin genotype pnl Bld/T | |
| 2019-08-20 | 93197-2 | CYP4F2 gene c.1297G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | CYP4F2 gene.c.1297G>A | Geno | Pt | Bld/Tiss | Nom | Molgen | CYP4F2 c.1297G>A Geno Bld/T | |
| 2019-08-20 | 93198-0 | 10q23 g.94645745G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | 10q23 g.94645745G>A | Geno | Pt | Bld/Tiss | Nom | Molgen | 10q23 g.94645745G>A Geno Bld/T | |
| 2019-08-20 | 93199-8 | DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | DPYD gene targeted mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | DPYD gene Mut Anl Bld/T | |
| 2019-08-20 | 93200-4 | Ehlers-Danlos syndrome multigene analysis in Blood or Tissue by Molecular genetics method | Ehlers-Danlos syndrome multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | EDS multigene Bld/T | |
| 2019-08-20 | 93201-2 | Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method | Coronary heart disease multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | CHD multigene analysis Bld/T | |
| 2019-08-12 | 93187-3 | Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel | Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel | - | Pt | ^Patient | - | Bone age assess TW2 panel | ||
| 2019-08-08 | 93129-5 | XR Radius Bone development stage | Bone development stage | Score | Pt | Upper extremity>Radius | Qn | XR | XR Radius Bone dev stage | |
| 2019-08-08 | 93130-3 | XR Trapezoid Bone development stage | Bone development stage | Score | Pt | Upper extremity>Wrist.trapezoid | Qn | XR | XR Trapezoid Bone dev stage | |
| 2019-08-08 | 93131-1 | XR Trapezium Bone development stage | Bone development stage | Score | Pt | Upper extremity>Wrist.trapezium | Qn | XR | XR Trapezium Bone dev stage | |
| 2019-08-08 | 93132-9 | XR Scaphoid Bone development stage | Bone development stage | Score | Pt | Upper extremity>Wrist.scaphoid | Qn | XR | XR Scaphoid Bone dev stage | |
| 2019-08-08 | 93133-7 | XR Lunate Bone development stage | Bone development stage | Score | Pt | Upper extremity>Wrist.lunate | Qn | XR | XR Lunate Bone dev stage | |
| 2019-08-08 | 93134-5 | XR Triquetrum Bone development stage | Bone development stage | Score | Pt | Upper extremity>Wrist.triquetrum | Qn | XR | XR Triquetrum Bone dev stage | |
| 2019-08-08 | 93135-2 | XR Hamate Bone development stage | Bone development stage | Score | Pt | Upper extremity>Wrist.hamate | Qn | XR | XR Hamate Bone dev stage | |
| 2019-08-08 | 93136-0 | XR Capitate Bone development stage | Bone development stage | Score | Pt | Upper extremity>Wrist.capitate | Qn | XR | XR Capitate Bone dev stage | |
| 2019-08-08 | 93137-8 | XR Distal phalanx of thumb Bone development stage | Bone development stage | Score | Pt | Upper extremity>Thumb.distal phalanx | Qn | XR | XR Thumb.distl phlnx Bone dev stage | |
| 2019-08-08 | 93138-6 | XR Distal phalanx of fifth finger Bone development stage | Bone development stage | Score | Pt | Upper extremity>Finger.fifth.distal phalanx | Qn | XR | XR Finger.5th.distl phlnx Bone dev stage | |
| 2019-08-08 | 93139-4 | XR Distal phalanx of third finger Bone development stage | Bone development stage | Score | Pt | Upper extremity>Finger.third.distal phalanx | Qn | XR | XR Finger.3rd.distl phlnx Bone dev stage | |
| 2019-08-08 | 93140-2 | XR Middle phalanx of third finger Bone development stage | Bone development stage | Score | Pt | Upper extremity>Finger.third.middle phalanx | Qn | XR | XR Finger.3rd.mid phlnx Bone dev stage | |
| 2019-08-08 | 93141-0 | XR Middle phalanx of fifth finger Bone development stage | Bone development stage | Score | Pt | Upper extremity>Finger.fifth.middle phalanx | Qn | XR | XR Finger.5th.mid phlnx Bone dev stage | |
| 2019-08-08 | 93142-8 | XR Proximal phalanx of fifth finger Bone development stage | Bone development stage | Score | Pt | Upper extremity>Finger.fifth.proximal phalanx | Qn | XR | XR Finger.5th.prox phlnx Bone dev stage | |
| 2019-08-08 | 93143-6 | XR Proximal phalanx of third finger Bone development stage | Bone development stage | Score | Pt | Upper extremity>Finger.third.proximal phalanx | Qn | XR | XR Finger.3rd.prox phlnx Bone dev stage | |
| 2019-08-08 | 93144-4 | XR Proximal phalanx of thumb Bone development stage | Bone development stage | Score | Pt | Upper extremity>Thumb.proximal phalanx | Qn | XR | XR Thumb.prox phlnx Bone dev stage | |
| 2019-08-08 | 93145-1 | XR Fifth metacarpal Bone development stage | Bone development stage | Score | Pt | Upper extremity>Hand.metacarpal.fifth | Qn | XR | XR Metacarpal.5th Bone dev stage | |
| 2019-08-08 | 93146-9 | XR Third metacarpal Bone development stage | Bone development stage | Score | Pt | Upper extremity>Hand.metacarpal.third | Qn | XR | XR Metacarpal.3rd Bone dev stage | |
| 2019-08-08 | 93148-5 | XR Ulna Bone development stage | Bone development stage | Score | Pt | Upper extremity>Ulna | Qn | XR | XR Ulna Bone dev stage | |
| 2019-08-08 | 93147-7 | XR First metacarpal Bone development stage | Bone development stage | Score | Pt | Upper extremity>Hand.metacarpal.first | Qn | XR | XR Metacarpal.1st Bone dev stage | |
| 2019-08-08 | 93149-3 | PhenX - bone age protocol 220301 | PhenX - bone age protocol 220301 | - | Pt | ^Patient | - | PhenX | PhenX bone age protocol | |
| 2019-08-08 | 93150-1 | Burn management procedure note | Procedure note | Find | Pt | {Setting} | Doc | Burn management | Burn Procedure note | |
| 2019-08-08 | 93151-9 | Radiology Team Conference note | Conference note | Find | Pt | {Setting} | Doc | Radiology.team | Radiology Team Conf eval note | |
| 2019-08-08 | 93152-7 | Radiology Initial evaluation note | Initial evaluation note | Find | Pt | {Setting} | Doc | Radiology | Radiology Initial eval note | |
| 2019-07-26 | 93127-9 | Risk adjustment factor [Score] | Risk adjustment factor | Score | Pt | ^Patient | Qn | RAF Score | ||
| 2019-07-25 | 93126-1 | Comparison with previous results | Comparison with previous results | Find | Pt | ^Patient | Doc | Comparison with previous results | ||
| 2019-07-24 | 93124-6 | New York Heart Association Functional Classification panel | New York Heart Association Functional Classification | - | Pt | ^Patient | - | NYHA | NYHA Functional Class | |
| 2019-07-24 | 93125-3 | Modified 30 seconds Sit to stand --with use of upper extremities | Sit to stand^with use of upper extremities | NRat | 30S | ^Patient | Qn | Modified 30s Sit to Stand w extremities | ||
| 2019-07-23 | 93122-0 | Contraindicated vaccine type [Identifier] | Contraindicated vaccine type | ID | Pt | ^Patient | Nom | Contraindicated vaccine | ||
| 2019-07-23 | 93123-8 | Preferred vaccine type [Identifier] | Preferred vaccine type | ID | Pt | ^Patient | Nom | Pref vaccine | ||
| 2019-07-22 | 93121-2 | Gabapentin [Presence] in Tissue by Screen method | Gabapentin | PrThr | Pt | Tiss | Ord | Screen | Gabapentin Tiss Ql Scn | |
| 2019-07-19 | 93118-8 | Difficulties in pregnancy total score [NuMoM2b] | Difficulties in Pregnancy total score | Score | Pt | ^Patient | Qn | NuMoM2b | ||
| 2019-07-19 | 93119-6 | Dark-mediated rod adaptation time Right eye | Dark-mediated rod adaptation time | Time | Pt | Eye.right | Qn | Dark rod adaptation tm Eye-R | ||
| 2019-07-19 | 93120-4 | Dark-mediated rod adaptation time Left eye | Dark-mediated rod adaptation time | Time | Pt | Eye.left | Qn | Dark rod adaptation tm Eye-L | ||
| 2019-07-10 | 93113-9 | Meaning of work [Quality of Working Life Questionnaire for Cancer Survivors] | Meaning of work | - | 4W | ^Patient | - | QWLQ-CS | ||
| 2019-07-10 | 93114-7 | Perception of your work situation [Quality of Working Life Questionnaire for Cancer Survivors] | Perception of your work situation | - | 4W | ^Patient | - | QWLQ-CS | ||
| 2019-07-10 | 93115-4 | Atmosphere in your working environment [Quality of Working Life Questionnaire for Cancer Survivors] | Atmosphere in your working environment | - | 4W | ^Patient | - | QWLQ-CS | ||
| 2019-07-10 | 93116-2 | Understanding and recognition in your organization [Quality of Working Life Questionnaire for Cancer Survivors] | Understanding and recognition in your organization | - | 4W | ^Patient | - | QWLQ-CS | ||
| 2019-07-10 | 93117-0 | Problems due to your health situation [Quality of Working Life Questionnaire for Cancer Survivors] | Problems due to your health situation | - | 4W | ^Patient | - | QWLQ-CS | ||
| 2019-07-09 | 93088-3 | Quality of Working Life Questionnaire for Cancer Survivors [Quality of Working Life Questionnaire for Cancer Survivors] | Quality of Working Life Questionnaire for Cancer Survivors | - | 4W | ^Patient | - | QWLQ-CS | ||
| 2019-07-09 | 93089-1 | During the past 4 weeks, working gives me structure in my life [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, working gives me structure in my life | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93090-9 | During the past 4 weeks, I think it is good to work [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I think it is good to work | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93091-7 | During the past 4 weeks, I consider that my work gives me a goal in life [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I consider that my work gives me a goal in life | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93092-5 | During the past 4 weeks, I consider my work important [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I consider my work important | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93093-3 | During the past 4 weeks, I do my work well [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I do my work well | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93094-1 | During the past 4 weeks, I am self-confident in my work [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I am self-confident in my work | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93095-8 | During the past 4 weeks, I am suited to my work [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I am suited to my work | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93096-6 | During the past 4 weeks, I have control over the work I do [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I have control over the work I do | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93097-4 | During the past 4 weeks, I feel powerless in my work [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I feel powerless in my work | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93098-2 | During the past 4 weeks, I feel there is a positive atmosphere in my working environment [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I feel there is a positive atmosphere in my working environment | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93099-0 | During the past 4 weeks, I have the feeling I am taken seriously by people in my working environment [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I have the feeling I am taken seriously by people in my working environment | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93101-4 | During the past 4 weeks, I have good relations with my colleagues [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I have good relations with my colleagues | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93100-6 | During the past 4 weeks, I am content with my work [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I am content with my work | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93102-2 | During the past 4 weeks, I feel valuable to my colleagues [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I feel valuable to my colleagues | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93103-0 | During the past 4 weeks, my immediate superior understands my health situation and possible health problems [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, my immediate superior understands my health situation and possible health problems | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93104-8 | During the past 4 weeks, I have good relations with my immediate superior [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I have good relations with my immediate superior | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93105-5 | During the past 4 weeks, I consider that employees with health problems are treated well in my organization [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I consider that employees with health problems are treated well in my organization | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93106-3 | During the past 4 weeks, I am content with the fringe benefits provided by my employer [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I am content with the fringe benefits provided by my employer | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93107-1 | During the past 4 weeks, I am content with my current income [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I am content with my current income | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93108-9 | During the past 4 weeks, because of my health situation I have problems in my work with fatigue/lack of energy [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93109-7 | During the past 4 weeks, I am limited in my work [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, I am limited in my work | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93110-5 | During the past 4 weeks, because of my health situation I have little trust in my own body [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, because of my health situation I have little trust in my own body | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93111-3 | During the past 4 weeks, because of my health situation I feel uncertain about the future [Quality of Working Life Questionnaire for Cancer Survivors] | During the past 4W, because of my health situation I feel uncertain about the future | Find | 4W | ^Patient | Ord | QWLQ-CS | ||
| 2019-07-09 | 93112-1 | Total score [Quality of Working Life Questionnaire for Cancer Survivors] | Total score | Score | Pt | ^Patient | Qn | QWLQ-CS | ||
| 2019-07-05 | 93086-7 | Obstetrics Emergency procedure note | Emergency procedure note | Find | Pt | {Setting} | Doc | Obstetrics | OB Emerg procedure note | |
| 2019-07-05 | 93087-5 | Total score [NuPDQ] | Total score | Score | Pt | ^Patient | Qn | NuPDQ | ||
| 2019-07-03 | 93085-9 | Dirofilaria immitis IgG Ab [Presence] in Serum by Immunoassay | Dirofilaria immitis Ab.IgG | PrThr | Pt | Ser | Ord | IA | D immitis IgG Ser Ql IA | |
| 2019-06-27 | 93073-5 | Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93076-8 | Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93074-3 | Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93075-0 | Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93079-2 | Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby [NuPDQ] | Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby | Find | Pt | ^Patient | Nom | NuPDQ | ||
| 2019-06-27 | 93078-4 | Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93077-6 | Physical symptom of pregnancy that you are feeling bothered, upset or worried about [NuPDQ] | Physical symptom of pregnancy that you are feeling bothered, upset or worried about | Find | Pt | ^Patient | Nom | NuPDQ | ||
| 2019-06-27 | 93080-0 | Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93081-8 | Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93083-4 | Revised Prenatal Distress Questionnaire (NuPDQ) - Concurrent Self-Administered Version | Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version | - | Pt | ^Patient | - | NuPDQ | ||
| 2019-06-27 | 93084-2 | NuMoM2b Difficulties in Pregnancy form [NuMoM2b] | Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form | - | Pt | ^Patient | - | NuMoM2b | ||
| 2019-06-27 | 93082-6 | Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93059-4 | Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93060-2 | Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93061-0 | Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93062-8 | Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93063-6 | Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93064-4 | Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting [NuMoM2b] | Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting | Find | Pt | ^Patient | Ord | NuMoM2b | ||
| 2019-06-27 | 93065-1 | Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet [NuMoM2b] | Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet | Find | Pt | ^Patient | Ord | NuMoM2b | ||
| 2019-06-27 | 93066-9 | Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches [NuMoM2b] | Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches | Find | Pt | ^Patient | Ord | NuMoM2b | ||
| 2019-06-27 | 93067-7 | Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93068-5 | Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93069-3 | Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93070-1 | Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby [NuPDQ] | Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-27 | 93071-9 | Other things you are feeling bothered, upset or worried about [NuPDQ] | Other things you are feeling bothered, upset or worried about | Find | Pt | ^Patient | Nom | NuPDQ | ||
| 2019-06-27 | 93072-7 | Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care [NuPDQ] | Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care | Find | Pt | ^Patient | Ord | NuPDQ | ||
| 2019-06-25 | 93055-2 | Outcome and assessment information set (OASIS) form - version D1 [CMS Assessment] | Outcome and assessment information set (OASIS) form - version D1 | - | Pt | ^Patient | - | CMS Assessment | ||
| 2019-06-25 | 93056-0 | OASIS D1 - Patient history and diagnoses - follow-up [CMS Assessment] | OASIS D1 - Patient history and diagnoses - follow-up | - | Pt | ^Patient | - | CMS Assessment | ||
| 2019-06-25 | 93057-8 | OASIS D1 - ADL and IADLs - follow-up [CMS Assessment] | OASIS D1 - ADL and IADLs - follow-up | - | Pt | ^Patient | - | CMS Assessment | ||
| 2019-06-25 | 93058-6 | Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up [CMS Assessment] | Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up | - | Pt | ^Patient | - | CMS Assessment | ||
| 2018-10-19 | 90568-7 | Polysomnography panel | Polysomnography panel | - | Stdy | ^Patient | - | Polysomnography Pnl |